Education
About Us
Working with TipRanks
Follow Us
Lantheus (LNTH)
NASDAQ:LNTH
Earnings Data
Report Date
Feb 19, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
1.19Last Year’s EPS
1.59Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements in leadership transition, strategic acquisitions, and product expansion, particularly in the Alzheimer's imaging market. However, these positives were counterbalanced by challenges in PYLARIFY sales, gross margins, and operating income declines. Despite the lowlights, the company's strategic positioning and future growth prospects in new areas like Alzheimer's imaging suggest a cautiously optimistic outlook.Company Guidance
Leadership Transition with Experienced Interim CEO
Brian Markison announced his retirement, with Mary Anne Heino, former CEO and current Board Chairperson, stepping in as interim CEO. This transition ensures continuity and leverages Heino's extensive industry experience.
Neuraceq Expansion and Growth
Neuraceq sales were consistent with expectations, and the company plans to expand its geographic coverage in the U.S. The product is expected to grow significantly due to rising Alzheimer's prevalence and expanded PET imaging guidelines.
Continued Success of DEFINITY
DEFINITY sales grew over 6% year-over-year, maintaining strong market leadership and demonstrating consistent performance in the ultrasound-enhancing agent market.
Strategic Acquisitions and Diversified Pipeline
Lantheus executed strategic transactions, including the acquisitions of Life Molecular Imaging and Evergreen Theragnostics, diversifying revenue streams and expanding capabilities across the radiopharmaceutical value chain.
MK-6240 Advances in Alzheimer's Imaging
MK-6240, a PET imaging agent for detecting tau in Alzheimer's disease, has a PDUFA date set for August 13, 2026, with promising trial results supporting its NDA submission.
LNTH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
LNTH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 06, 2025 | $57.23 | $53.69 | -6.19% |
Aug 06, 2025 | $72.63 | $51.87 | -28.58% |
May 07, 2025 | $104.84 | $80.49 | -23.23% |
Feb 26, 2025 | $80.05 | $93.25 | +16.49% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Lantheus (LNTH) report earnings?
Lantheus (LNTH) is schdueled to report earning on Feb 19, 2026, After Close (Confirmed).
What is Lantheus (LNTH) earnings time?
Lantheus (LNTH) earnings time is at Feb 19, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LNTH EPS forecast?
LNTH EPS forecast for the fiscal quarter 2025 (Q4) is 1.19.
